معرفی
Hanming Zhang is an Associate Research Scientist in the Department of Internal Medicine at Yale School of Medicine, specializing in vascular biology and metabolic disease. He is a key member of the Fernández-Hernando Lab and collaborates extensively with researchers such as Carlos Fernández-Hernando, Yajaira Suárez, and Daniel Greif.
- PhD: University of South Dakota (2019)
- BS: Zhejiang Sci-Tech University (2012)
His research focuses on the molecular mechanisms underlying atherosclerosis, endothelial dysfunction, liver disease (NAFLD/NASH), and cardiovascular complications of SARS-CoV-2 infection. He investigates lipid metabolism, smooth muscle cell signaling, microRNA regulation, and inflammatory pathways in vascular and hepatic systems.
The recent articles highlight a strong trend in studying metabolic regulation in vascular and liver pathologies, with a particular emphasis on LXR signaling, miR-33, USP25, and endothelial triglyceride metabolism. His work bridges basic science with translational applications in obesity-related heart disease, Long COVID, and atherosclerosis.
Scientific Awards:
- AHA Postdoctoral Fellowship
- BCVS New Investigator Travel Award
- Best Abstract-based Oral Presentation
- Outstanding Young Investigator Award
- AHA Predoctoral Fellowship
Hanming Zhang has not advised any students listed in the provided text and has not received public recognition for grants. He is actively engaged in collaborative research within the Vascular Biology & Therapeutics Program and contributes to Yale’s interdisciplinary research initiatives in metabolism and inflammation.
Lab Affiliation: Fernández-Hernando Lab, located at 10 Amistad Street, Room 320, New Haven, CT.